Litigation Details for Pharmacyclics LLC v. Alvogen Pine Brook, LLC (D. Del. 2020)
✉ Email this page to a colleague
Pharmacyclics LLC v. Alvogen Pine Brook, LLC (D. Del. 2020)
| Docket | ⤷ Start Trial | Date Filed | 2020-03-20 |
| Court | District Court, D. Delaware | Date Terminated | 2021-04-13 |
| Cause | 35:271 Patent Infringement | Assigned To | Colm Felix Connolly |
| Jury Demand | Defendant | Referred To | |
| Parties | PHARMACYCLICS LLC | ||
| Patents | 10,010,507; 10,213,386; 10,463,668; 10,478,439; 10,653,696; 10,695,350; 10,752,634; 7,514,444; 8,008,309; 8,476,284; 8,497,277; 8,697,711; 8,703,780; 8,735,403; 8,754,090; 8,754,091; 8,952,015; 8,999,999; 9,125,889; 9,296,753; 9,540,382; 9,655,857; 9,713,617; 9,725,455; 9,795,604 | ||
| Attorneys | James L. Higgins | ||
| Firms | Heyman Enerio Gattuso & Hirzel LLP | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Pharmacyclics LLC v. Alvogen Pine Brook, LLC
The small molecule drug covered by the patents cited in this case is ⤷ Start Trial .
Details for Pharmacyclics LLC v. Alvogen Pine Brook, LLC (D. Del. 2020)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2020-03-20 | External link to document | |||
| 2020-03-20 | 1 | Complaint | prior to the expiration of U.S. Patent No. 10,478,439 (“the ’439 Patent”). Zydus has submitted amendments…. This action for patent infringement, brought pursuant to the patent laws of the United States…action for infringement of the ’439 Patent. 3. Other patent infringement actions relating to…46. This civil action for patent infringement arises under the patent laws of the United States, including… THE ASSERTED PATENT 102. The ’439 Patent, entitled “Use of Inhibitors of | External link to document |
| 2020-03-20 | 19 | Complaint - Amended | expiration of the ’439 Patent and U.S. Patent No. 10,463,668 (“the ’668 Patent”). Alvogen- Natco has …. This action for patent infringement, brought pursuant to the patent laws of the United States…prior to the expiration of U.S. Patent No. 10,478,439 (“the ’439 Patent”). Zydus has submitted amendments…infringement of the ’439 and ’668 Patents. 3. Other patent infringement actions relating to…The ’439 Patent is listed in the Orange Book for IMBRUVICA®. 12. The ’668 Patent is listed | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
Litigation summary and analysis for: Pharmacyclics LLC v. Alvogen Pine Brook, LLC (D. Del. 2020)
More… ↓
